RhumbLine Advisers’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-83,369
| Closed | -$73K | – | 4232 |
|
|
2025
Q1 | $73K | Buy |
83,369
+2,868
| +4% | +$2.51K | ﹤0.01% | 3482 |
|
|
2024
Q4 | $136K | Sell |
80,501
-9,892
| -11% | -$16.7K | ﹤0.01% | 3376 |
|
|
2024
Q3 | $174K | Buy |
90,393
+14,203
| +19% | +$27.3K | ﹤0.01% | 3306 |
|
|
2024
Q2 | $187K | Buy |
76,190
+6,181
| +9% | +$15.2K | ﹤0.01% | 3262 |
|
|
2024
Q1 | $115K | Buy |
70,009
+801
| +1% | +$1.31K | ﹤0.01% | 3398 |
|
|
2023
Q4 | $123K | Buy |
69,208
+564
| +0.8% | +$1K | ﹤0.01% | 3380 |
|
|
2023
Q3 | $314K | Sell |
68,644
-8,779
| -11% | -$40.2K | ﹤0.01% | 2910 |
|
|
2023
Q2 | $866K | Buy |
+77,423
| New | +$866K | ﹤0.01% | 2373 |
|